Tag Archives: part

#432880 Google’s Duplex Raises the Question: ...

By now, you’ve probably seen Google’s new Duplex software, which promises to call people on your behalf to book appointments for haircuts and the like. As yet, it only exists in demo form, but already it seems like Google has made a big stride towards capturing a market that plenty of companies have had their eye on for quite some time. This software is impressive, but it raises questions.

Many of you will be familiar with the stilted, robotic conversations you can have with early chatbots that are, essentially, glorified menus. Instead of pressing 1 to confirm or 2 to re-enter, some of these bots would allow for simple commands like “Yes” or “No,” replacing the buttons with limited ability to recognize a few words. Using them was often a far more frustrating experience than attempting to use a menu—there are few things more irritating than a robot saying, “Sorry, your response was not recognized.”

Google Duplex scheduling a hair salon appointment:

Google Duplex calling a restaurant:

Even getting the response recognized is hard enough. After all, there are countless different nuances and accents to baffle voice recognition software, and endless turns of phrase that amount to saying the same thing that can confound natural language processing (NLP), especially if you like your phrasing quirky.

You may think that standard customer-service type conversations all travel the same route, using similar words and phrasing. But when there are over 80,000 ways to order coffee, and making a mistake is frowned upon, even simple tasks require high accuracy over a huge dataset.

Advances in audio processing, neural networks, and NLP, as well as raw computing power, have meant that basic recognition of what someone is trying to say is less of an issue. Soundhound’s virtual assistant prides itself on being able to process complicated requests (perhaps needlessly complicated).

The deeper issue, as with all attempts to develop conversational machines, is one of understanding context. There are so many ways a conversation can go that attempting to construct a conversation two or three layers deep quickly runs into problems. Multiply the thousands of things people might say by the thousands they might say next, and the combinatorics of the challenge runs away from most chatbots, leaving them as either glorified menus, gimmicks, or rather bizarre to talk to.

Yet Google, who surely remembers from Glass the risk of premature debuts for technology, especially the kind that ask you to rethink how you interact with or trust in software, must have faith in Duplex to show it on the world stage. We know that startups like Semantic Machines and x.ai have received serious funding to perform very similar functions, using natural-language conversations to perform computing tasks, schedule meetings, book hotels, or purchase items.

It’s no great leap to imagine Google will soon do the same, bringing us closer to a world of onboard computing, where Lens labels the world around us and their assistant arranges it for us (all the while gathering more and more data it can convert into personalized ads). The early demos showed some clever tricks for keeping the conversation within a fairly narrow realm where the AI should be comfortable and competent, and the blog post that accompanied the release shows just how much effort has gone into the technology.

Yet given the privacy and ethics funk the tech industry finds itself in, and people’s general unease about AI, the main reaction to Duplex’s impressive demo was concern. The voice sounded too natural, bringing to mind Lyrebird and their warnings of deepfakes. You might trust “Do the Right Thing” Google with this technology, but it could usher in an era when automated robo-callers are far more convincing.

A more human-like voice may sound like a perfectly innocuous improvement, but the fact that the assistant interjects naturalistic “umm” and “mm-hm” responses to more perfectly mimic a human rubbed a lot of people the wrong way. This wasn’t just a voice assistant trying to sound less grinding and robotic; it was actively trying to deceive people into thinking they were talking to a human.

Google is running the risk of trying to get to conversational AI by going straight through the uncanny valley.

“Google’s experiments do appear to have been designed to deceive,” said Dr. Thomas King of the Oxford Internet Institute’s Digital Ethics Lab, according to Techcrunch. “Their main hypothesis was ‘can you distinguish this from a real person?’ In this case it’s unclear why their hypothesis was about deception and not the user experience… there should be some kind of mechanism there to let people know what it is they are speaking to.”

From Google’s perspective, being able to say “90 percent of callers can’t tell the difference between this and a human personal assistant” is an excellent marketing ploy, even though statistics about how many interactions are successful might be more relevant.

In fact, Duplex runs contrary to pretty much every major recommendation about ethics for the use of robotics or artificial intelligence, not to mention certain eavesdropping laws. Transparency is key to holding machines (and the people who design them) accountable, especially when it comes to decision-making.

Then there are the more subtle social issues. One prominent effect social media has had is to allow people to silo themselves; in echo chambers of like-minded individuals, it’s hard to see how other opinions exist. Technology exacerbates this by removing the evolutionary cues that go along with face-to-face interaction. Confronted with a pair of human eyes, people are more generous. Confronted with a Twitter avatar or a Facebook interface, people hurl abuse and criticism they’d never dream of using in a public setting.

Now that we can use technology to interact with ever fewer people, will it change us? Is it fair to offload the burden of dealing with a robot onto the poor human at the other end of the line, who might have to deal with dozens of such calls a day? Google has said that if the AI is in trouble, it will put you through to a human, which might help save receptionists from the hell of trying to explain a concept to dozens of dumbfounded AI assistants all day. But there’s always the risk that failures will be blamed on the person and not the machine.

As AI advances, could we end up treating the dwindling number of people in these “customer-facing” roles as the buggiest part of a fully automatic service? Will people start accusing each other of being robots on the phone, as well as on Twitter?

Google has provided plenty of reassurances about how the system will be used. They have said they will ensure that the system is identified, and it’s hardly difficult to resolve this problem; a slight change in the script from their demo would do it. For now, consumers will likely appreciate moves that make it clear whether the “intelligent agents” that make major decisions for us, that we interact with daily, and that hide behind social media avatars or phone numbers are real or artificial.

Image Credit: Besjunior / Shutterstock.com Continue reading

Posted in Human Robots

#432691 Is the Secret to Significantly Longer ...

Once upon a time, a powerful Sumerian king named Gilgamesh went on a quest, as such characters often do in these stories of myth and legend. Gilgamesh had witnessed the death of his best friend, Enkidu, and, fearing a similar fate, went in search of immortality. The great king failed to find the secret of eternal life but took solace that his deeds would live well beyond his mortal years.

Fast-forward four thousand years, give or take a century, and Gilgamesh (as famous as any B-list celebrity today, despite the passage of time) would probably be heartened to learn that many others have taken up his search for longevity. Today, though, instead of battling epic monsters and the machinations of fickle gods, those seeking to enhance and extend life are cutting-edge scientists and visionary entrepreneurs who are helping unlock the secrets of human biology.

Chief among them is Aubrey de Grey, a biomedical gerontologist who founded the SENS Research Foundation, a Silicon Valley-based research organization that seeks to advance the application of regenerative medicine to age-related diseases. SENS stands for Strategies for Engineered Negligible Senescence, a term coined by de Grey to describe a broad array (seven, to be precise) of medical interventions that attempt to repair or prevent different types of molecular and cellular damage that eventually lead to age-related diseases like cancer and Alzheimer’s.

Many of the strategies focus on senescent cells, which accumulate in tissues and organs as people age. Not quite dead, senescent cells stop dividing but are still metabolically active, spewing out all sorts of proteins and other molecules that can cause inflammation and other problems. In a young body, that’s usually not a problem (and probably part of general biological maintenance), as a healthy immune system can go to work to put out most fires.

However, as we age, senescent cells continue to accumulate, and at some point the immune system retires from fire watch. Welcome to old age.

Of Mice and Men
Researchers like de Grey believe that treating the cellular underpinnings of aging could not only prevent disease but significantly extend human lifespans. How long? Well, if you’re talking to de Grey, Biblical proportions—on the order of centuries.

De Grey says that science has made great strides toward that end in the last 15 years, such as the ability to copy mitochondrial DNA to the nucleus. Mitochondria serve as the power plant of the cell but are highly susceptible to mutations that lead to cellular degeneration. Copying the mitochondrial DNA into the nucleus would help protect it from damage.

Another achievement occurred about six years ago when scientists first figured out how to kill senescent cells. That discovery led to a spate of new experiments in mice indicating that removing these ticking-time-bomb cells prevented disease and even extended their lifespans. Now the anti-aging therapy is about to be tested in humans.

“As for the next few years, I think the stream of advances is likely to become a flood—once the first steps are made, things get progressively easier and faster,” de Grey tells Singularity Hub. “I think there’s a good chance that we will achieve really dramatic rejuvenation of mice within only six to eight years: maybe taking middle-aged mice and doubling their remaining lifespan, which is an order of magnitude more than can be done today.”

Not Horsing Around
Richard G.A. Faragher, a professor of biogerontology at the University of Brighton in the United Kingdom, recently made discoveries in the lab regarding the rejuvenation of senescent cells with chemical compounds found in foods like chocolate and red wine. He hopes to apply his findings to an animal model in the future—in this case,horses.

“We have been very fortunate in receiving some funding from an animal welfare charity to look at potential treatments for older horses,” he explains to Singularity Hub in an email. “I think this is a great idea. Many aspects of the physiology we are studying are common between horses and humans.”

What Faragher and his colleagues demonstrated in a paper published in BMC Cell Biology last year was that resveralogues, chemicals based on resveratrol, were able to reactivate a protein called a splicing factor that is involved in gene regulation. Within hours, the chemicals caused the cells to rejuvenate and start dividing like younger cells.

“If treatments work in our old pony systems, then I am sure they could be translated into clinical trials in humans,” Faragher says. “How long is purely a matter of money. Given suitable funding, I would hope to see a trial within five years.”

Show Them the Money
Faragher argues that the recent breakthroughs aren’t because a result of emerging technologies like artificial intelligence or the gene-editing tool CRISPR, but a paradigm shift in how scientists understand the underpinnings of cellular aging. Solving the “aging problem” isn’t a question of technology but of money, he says.

“Frankly, when AI and CRISPR have removed cystic fibrosis, Duchenne muscular dystrophy or Gaucher syndrome, I’ll be much more willing to hear tales of amazing progress. Go fix a single, highly penetrant genetic disease in the population using this flashy stuff and then we’ll talk,” he says. “My faith resides in the most potent technological development of all: money.”

De Grey is less flippant about the role that technology will play in the quest to defeat aging. AI, CRISPR, protein engineering, advances in stem cell therapies, and immune system engineering—all will have a part.

“There is not really anything distinctive about the ways in which these technologies will contribute,” he says. “What’s distinctive is that we will need all of these technologies, because there are so many different types of damage to repair and they each require different tricks.”

It’s in the Blood
A startup in the San Francisco Bay Area believes machines can play a big role in discovering the right combination of factors that lead to longer and healthier lives—and then develop drugs that exploit those findings.

BioAge Labs raised nearly $11 million last year for its machine learning platform that crunches big data sets to find blood factors, such as proteins or metabolites, that are tied to a person’s underlying biological age. The startup claims that these factors can predict how long a person will live.

“Our interest in this comes out of research into parabiosis, where joining the circulatory systems of old and young mice—so that they share the same blood—has been demonstrated to make old mice healthier and more robust,” Dr. Eric Morgen, chief medical officer at BioAge, tells Singularity Hub.

Based on that idea, he explains, it should be possible to alter those good or bad factors to produce a rejuvenating effect.

“Our main focus at BioAge is to identify these types of factors in our human cohort data, characterize the important molecular pathways they are involved in, and then drug those pathways,” he says. “This is a really hard problem, and we use machine learning to mine these complex datasets to determine which individual factors and molecular pathways best reflect biological age.”

Saving for the Future
Of course, there’s no telling when any of these anti-aging therapies will come to market. That’s why Forever Labs, a biotechnology startup out of Ann Arbor, Michigan, wants your stem cells now. The company offers a service to cryogenically freeze stem cells taken from bone marrow.

The theory behind the procedure, according to Forever Labs CEO Steven Clausnitzer, is based on research showing that stem cells may be a key component for repairing cellular damage. That’s because stem cells can develop into many different cell types and can divide endlessly to replenish other cells. Clausnitzer notes that there are upwards of a thousand clinical studies looking at using stem cells to treat age-related conditions such as cardiovascular disease.

However, stem cells come with their own expiration date, which usually coincides with the age that most people start experiencing serious health problems. Stem cells harvested from bone marrow at a younger age can potentially provide a therapeutic resource in the future.

“We believe strongly that by having access to your own best possible selves, you’re going to be well positioned to lead healthier, longer lives,” he tells Singularity Hub.

“There’s a compelling argument to be made that if you started to maintain the bone marrow population, the amount of nuclear cells in your bone marrow, and to re-up them so that they aren’t declining with age, it stands to reason that you could absolutely mitigate things like cardiovascular disease and stroke and Alzheimer’s,” he adds.

Clausnitzer notes that the stored stem cells can be used today in developing therapies to treat chronic conditions such as osteoarthritis. However, the more exciting prospect—and the reason he put his own 38-year-old stem cells on ice—is that he believes future stem cell therapies can help stave off the ravages of age-related disease.

“I can start reintroducing them not to treat age-related disease but to treat the decline in the stem-cell niche itself, so that I don’t ever get an age-related disease,” he says. “I don’t think that it equates to immortality, but it certainly is a step in that direction.”

Indecisive on Immortality
The societal implications of a longer-living human species are a guessing game at this point. We do know that by mid-century, the global population of those aged 65 and older will reach 1.6 billion, while those older than 80 will hit nearly 450 million, according to the National Academies of Science. If many of those people could enjoy healthy lives in their twilight years, an enormous medical cost could be avoided.

Faragher is certainly working toward a future where human health is ubiquitous. Human immortality is another question entirely.

“The longer lifespans become, the more heavily we may need to control birth rates and thus we may have fewer new minds. This could have a heavy ‘opportunity cost’ in terms of progress,” he says.

And does anyone truly want to live forever?

“There have been happy moments in my life but I have also suffered some traumatic disappointments. No [drug] will wash those experiences out of me,” Faragher says. “I no longer view my future with unqualified enthusiasm, and I do not think I am the only middle-aged man to feel that way. I don’t think it is an accident that so many ‘immortalists’ are young.

“They should be careful what they wish for.”

Image Credit: Karim Ortiz / Shutterstock.com Continue reading

Posted in Human Robots

#432685 Inside TickTock’s Consumer Robot ...

Ryan Hickman, who co-founded the Cloud Robotics group at Google and was an early part of the Toyota Research Institute Product team, describes how his startup tried to make consumer home robots work Continue reading

Posted in Human Robots

#432646 How Fukushima Changed Japanese Robotics ...

In March 2011, Japan was hit by a catastrophic earthquake that triggered a terrible tsunami. Thousands were killed and billions of dollars of damage was done in one of the worst disasters of modern times. For a few perilous weeks, though, the eyes of the world were focused on the Fukushima Daiichi nuclear power plant. Its safety systems were unable to cope with the tsunami damage, and there were widespread fears of another catastrophic meltdown that could spread radiation over several countries, like the Chernobyl disaster in the 1980s. A heroic effort that included dumping seawater into the reactor core prevented an even bigger catastrophe. As it is, a hundred thousand people are still evacuated from the area, and it will likely take many years and hundreds of billions of dollars before the region is safe.

Because radiation is so dangerous to humans, the natural solution to the Fukushima disaster was to send in robots to monitor levels of radiation and attempt to begin the clean-up process. The techno-optimists in Japan had discovered a challenge, deep in the heart of that reactor core, that even their optimism could not solve. The radiation fried the circuits of the robots that were sent in, even those specifically designed and built to deal with the Fukushima catastrophe. The power plant slowly became a vast robot graveyard. While some robots initially saw success in measuring radiation levels around the plant—and, recently, a robot was able to identify the melted uranium fuel at the heart of the disaster—hopes of them playing a substantial role in the clean-up are starting to diminish.



In Tokyo’s neon Shibuya district, it can sometimes seem like it’s brighter at night than it is during the daytime. In karaoke booths on the twelfth floor—because everything is on the twelfth floor—overlooking the brightly-lit streets, businessmen unwind by blasting out pop hits. It can feel like the most artificial place on Earth; your senses are dazzled by the futuristic techno-optimism. Stock footage of the area has become symbolic of futurism and modernity.

Japan has had a reputation for being a nation of futurists for a long time. We’ve already described how tech giant Softbank, headed by visionary founder Masayoshi Son, is investing billions in a technological future, including plans for the world’s largest solar farm.

When Google sold pioneering robotics company Boston Dynamics in 2017, Softbank added it to their portfolio, alongside the famous Nao and Pepper robots. Some may think that Son is taking a gamble in pursuing a robotics project even Google couldn’t succeed in, but this is a man who lost nearly everything in the dot-com crash of 2000. The fact that even this reversal didn’t dent his optimism and faith in technology is telling. But how long can it last?

The failure of Japan’s robots to deal with the immense challenge of Fukushima has sparked something of a crisis of conscience within the industry. Disaster response is an obvious stepping-stone technology for robots. Initially, producing a humanoid robot will be very costly, and the robot will be less capable than a human; building a robot to wait tables might not be particularly economical yet. Building a robot to do jobs that are too dangerous for humans is far more viable. Yet, at Fukushima, in one of the most advanced nations in the world, many of the robots weren’t up to the task.

Nowhere was this crisis more felt than Honda; the company had developed ASIMO, which stunned the world in 2000 and continues to fascinate as an iconic humanoid robot. Despite all this technological advancement, however, Honda knew that ASIMO was still too unreliable for the real world.

It was Fukushima that triggered a sea-change in Honda’s approach to robotics. Two years after the disaster, there were rumblings that Honda was developing a disaster robot, and in October 2017, the prototype was revealed to the public for the first time. It’s not yet ready for deployment in disaster zones, however. Interestingly, the creators chose not to give it dexterous hands but instead to assume that remotely-operated tools fitted to the robot would be a better solution for the range of circumstances it might encounter.

This shift in focus for humanoid robots away from entertainment and amusement like ASIMO, and towards being practically useful, has been mirrored across the world.

In 2015, also inspired by the Fukushima disaster and the lack of disaster-ready robots, the DARPA Robotics Challenge tested humanoid robots with a range of tasks that might be needed in emergency response, such as driving cars, opening doors, and climbing stairs. The Terminator-like ATLAS robot from Boston Dynamics, alongside Korean robot HUBO, took many of the plaudits, and CHIMP also put in an impressive display by being able to right itself after falling.

Yet the DARPA Robotics Challenge showed us just how far the robots are from truly being as useful as we’d like, or maybe even as we would imagine. Many robots took hours to complete the tasks, which were highly idealized to suit them. Climbing stairs proved a particular challenge. Those who watched were more likely to see a robot that had fallen over, struggling to get up, rather than heroic superbots striding in to save the day. The “striding” proved a particular problem, with the fastest robot HUBO managing this by resorting to wheels in its knees when the legs weren’t necessary.

Fukushima may have brought a sea-change over futuristic Japan, but before robots will really begin to enter our everyday lives, they will need to prove their worth. In the interim, aerial drone robots designed to examine infrastructure damage after disasters may well see earlier deployment and more success.

It’s a considerable challenge.

Building a humanoid robot is expensive; if these multi-million-dollar machines can’t help in a crisis, people may begin to question the worth of investing in them in the first place (unless your aim is just to make viral videos). This could lead to a further crisis of confidence among the Japanese, who are starting to rely on humanoid robotics as a solution to the crisis of the aging population. The Japanese government, as part of its robots strategy, has already invested $44 million in their development.

But if they continue to fail when put to the test, that will raise serious concerns. In Tokyo’s Akihabara district, you can see all kinds of flash robotic toys for sale in the neon-lit superstores, and dancing, acting robots like Robothespian can entertain crowds all over the world. But if we want these machines to be anything more than toys—partners, helpers, even saviors—more work needs to be done.

At the same time, those who participated in the DARPA Robotics Challenge in 2015 won’t be too concerned if people were underwhelmed by the performance of their disaster relief robots. Back in 2004, nearly every participant in the DARPA Grand Challenge crashed, caught fire, or failed on the starting line. To an outside observer, the whole thing would have seemed like an unmitigated disaster, and a pointless investment. What was the task in 2004? Developing a self-driving car. A lot can change in a decade.

Image Credit: MARCUSZ2527 / Shutterstock.com Continue reading

Posted in Human Robots

#432572 Robots Can Swim, Fetch, Lift, and Dance. ...

Robotics has come a long way in the past few years. Robots can now fetch items from specific spots in massive warehouses, swim through the ocean to study marine life, and lift 200 times their own weight. They can even perform synchronized dance routines.

But the really big question is—can robots put together an Ikea chair?

A team of engineers from Nanyang Technological University in Singapore decided to find out, detailing their work in a paper published last week in the journal Science Robotics. The team took industrial robot arms and equipped them with parallel grippers, force-detecting sensors, and 3D cameras, and wrote software enabling the souped-up bots to tackle chair assembly. The robots’ starting point was a set of chair parts randomly scattered within reach.

As impressive as the above-mentioned robotic capabilities are, it’s worth noting that they’re mostly limited to a single skill. Putting together furniture, on the other hand, requires using and precisely coordinating multiple skills, including force control, visual localization, hand-eye coordination, and the patience to read each step of the manual without rushing through it and messing everything up.

Indeed, Ikea furniture, while meant to be simple and user-friendly, has left even the best of us scratching our heads and holding a spare oddly-shaped piece of wood as we stare at the desk or bed frame we just put together—or, for the less even-tempered among us, throwing said piece of wood across the room.

It’s a good thing robots don’t have tempers, because it took a few tries for the bots to get the chair assembly right.

Practice makes perfect, though (or in this case, rewriting code makes perfect), and these bots didn’t give up so easily. They had to hone three different skills: identifying which part was which among the scattered, differently-shaped pieces of wood, coordinating their movements to put those pieces in the right place, and knowing how much force to use in various steps of the process (i.e., more force is needed to connect two pieces than to pick up one piece).

A few tries later, the bots were able to assemble the chair from start to finish in about nine minutes.

On the whole, nicely done. But before we applaud the robots’ success too loudly, it’s important to note that they didn’t autonomously assemble the chair. Rather, each step of the process was planned and coded by engineers, down to the millimeter.

However, the team believes this closely-guided chair assembly was just a first step, and they see a not-so-distant future where combining artificial intelligence with advanced robotic capabilities could produce smart bots that would learn to assemble furniture and do other complex tasks on their own.

Future applications mentioned in the paper include electronics and aircraft manufacturing, logistics, and other high-mix, low-volume sectors.

Image Credit: Francisco Suárez-Ruiz and Quang-Cuong Pham/Nanyang Technological University Continue reading

Posted in Human Robots